CMS Gene therapy Actin FoxO Expanded repeats Antisense morpholino Atrial cardiac defects Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Eteplirsen DM1 myoblasts Folding-defective proteins ITSN1 Emerin Alternative splicing Lamina-associated domain CFTR correctors Cell Therapy Fibroblast Human muscle stem/progenitor cells Immortalized dystrophic canine myoblast Cell-penetrating peptide CXCL12 Adeno-associated viral vector DsDNA break repair Allele-specific silencing CTG⋅CAGn repeat Dynamin 2 RNA interference Drisapersen CDNA synthesis Skeletal muscle Motor neuron Dystrophin Exondys 51 CRISPR/Cas9 Dominant centronuclear myopathy 3D co-culture Endocytosis Exon-skipping Glucose HDMD/Dmd-null mice Autophagy Conjugation Insulin Muscle Becker muscular dystrophy Gene network analysis Laminographie DNM2 LTβR Acetylcholine receptor subunit epsilon BMD Mdx52 mice KLF15 Antisense oligonucleotide LRP4 ICU-acquired weakness MT RNA/DNA Editing Migration DMD Bile acid BAF Centronuclear myopathy Differentiation Gene Therapy Exon skipping FSHD Allele-specific silencing therapy Computer software Myogenesis Duchenne Muscular Dystrophy Fear response Coculture Exon Skipping Mdx Lymphotoxin-β-receptor Gel electrophoresis Chromatin Developmental biology Cell biology Immortalisation CXCR4 Fibrosis Canine X-linked muscular dystrophy in Japan CXMD J Myotube Neuromuscular junction Flavonoid MSCs Gut microbiota CLS Lamin A/C nuclei Adhesion Myotonic dystrophy Glucocorticoid-induced muscle atrophy Clinical trial candidate screening Duchenne muscular dystrophy Human Human artificial chromosomes Autophagosome Machine learning